Wu Tong (Nmn) reported grant involving 2,431 derivative units of WATERS CORP DE at $0.00 for $0 on Nov 12, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
SVP Waters Analytical Sciences
SVP Waters Analytical Sciences
Filed Nov 16, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
2,431Stock Option (Right to Buy)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
2,431Direct
Trade date
Nov 12, 2026Grant
Filed
Nov 16, 2026, 4:42 PM ET4-day reporting delay
Accession
0001000697-26-000148Code A · Transaction 401899
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 12, 2026Grant1,081$0.00$0Trade 401898
2 transaction rows in this filing. Joint filers share the same rows.

WAT price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
WAT · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 23, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −7.3%1w ago 0%1d ago 0%
Returns since7d30d90d180d1y

Footnotes in full

F1: Represents restricted stock units ("RSUs"), which will vest in four substantially equal annual installments, with the first such installment vesting on the first anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer on each such vesting date. The RSUs are convertible into shares of the Issuer's common stock on a one-to-one basis upon vesting and settlement. F2: The shares of common stock underlying this stock option will vest and become exercisable in four substantially equal annual installments, with the first such installment vesting and becoming exercisable on the first anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer on each such vesting date.